Milestone Pharmaceuticals Inc. Shares Outstanding (Cover Page)
Milestone Pharmaceuticals Inc. (MIST) had Shares Outstanding (Cover Page) of 124.50 million shares as of 2026-08-12, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-12: Entity Common Stock, Shares Outstanding 124.50M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 124.50M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 117.67M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 85.17M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 124.50M shares 10-Q · filed 2026-08-12 |
| 2026-05-13 | 124.50M shares 10-Q · filed 2026-05-13 |
| 2026-03-20 | 117.67M shares 10-K · filed 2026-03-20 |
| 2025-11-12 | 85.17M shares 10-Q · filed 2025-11-12 |
| 2025-08-12 | 84.99M shares 10-Q · filed 2025-08-12 |
| 2025-05-14 | 53.46M shares 10-Q · filed 2025-05-14 |
| 2025-03-13 | 53.35M shares 10-K · filed 2025-03-13 |
| 2024-11-12 | 53.33M shares 10-Q · filed 2024-11-12 |
| 2024-08-08 | 53.27M shares 10-Q · filed 2024-08-08 |
| 2024-05-13 | 53.26M shares 10-Q · filed 2024-05-13 |
| 2024-03-21 | 53.15M shares 10-K/A · filed 2024-04-29 |
| 2023-11-13 | 33.48M shares 10-Q · filed 2023-11-13 |
| 2023-08-10 | 33.38M shares 10-Q · filed 2023-08-10 |
| 2023-05-11 | 33.36M shares 10-Q · filed 2023-05-11 |
| 2023-03-29 | 33.29M shares 10-K/A · filed 2023-05-31 |
| 2022-11-10 | 34.29M shares 10-Q · filed 2022-11-10 |
| 2022-08-10 | 30.01M shares 10-Q · filed 2022-08-10 |
| 2022-05-04 | 29.93M shares 10-Q · filed 2022-05-12 |
| 2022-03-21 | 29.92M shares 10-K · filed 2022-03-24 |
| 2021-11-04 | 29.87M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 29.85M shares 10-Q · filed 2021-08-11 |
| 2021-05-03 | 29.85M shares 10-Q · filed 2021-05-17 |
| 2021-03-05 | 29.85M shares 10-K · filed 2021-03-29 |
| 2020-11-06 | 29.82M shares 10-Q · filed 2020-11-13 |
| 2020-08-03 | 24.71M shares 10-Q · filed 2020-08-12 |
| 2020-05-01 | 24.61M shares 10-Q · filed 2020-05-14 |
| 2020-03-03 | 24.56M shares 10-K/A · filed 2020-10-23 |
| 2019-11-01 | 24.49M shares 10-Q · filed 2019-11-13 |
| 2019-08-07 | 24.49M shares 10-Q · filed 2019-08-13 |
| 2019-06-14 | 24.49M shares 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |